AIDS Alert Archives – April 1, 2008
April 1, 2008
View Issues
-
President's HIV funding proposal is dead on arrival, HIV advocates say
HIV/AIDS advocates say President Bush's FY 2009 appropriations for federal HIV/AIDS programs, which flat-funds HIV programs, is dead on arrival. They say it seals his legacy as being apathetic towards the domestic epidemic and science-based prevention interventions. -
CDC and investigators find success with intervention in HIV clinics
The more scientists and public health officials learn about HIV prevention, the more they realize that targeting specific cultural and demographic groups of people who are not infected is a costly and labor-intensive venture. -
U.S. Virgin Islands and Caribbean HIV epidemic need more attention, researchers say
The Caribbean receives scant attention from HIV researchers and public health officials, and this has resulted in an epidemic that is poorly understood, an investigator says. -
FDA issues warning for nonoxynol-9 products
Over-the-counter contraceptive products that contain the spermicide nonoxynol-9 (N-9) now will carry a warning label to alert consumers that such products do not protect against sexually transmitted diseases (STDs) and HIV/AIDS, following a final ruling by the Food and Drug Administration (FDA). -
Therapeutic trial of growth hormone releasing factor in HIV patients
This multicenter, randomized, placebo-controlled trial of a synthetic GHRH analogue, tesamorelin (1-44 amino acids from the amino terminal of GHRH with a trans-3-hexenoyl group added to the amino terminal to increase the half-life over native GHRH), randomized 412 patients (86% male) to daily subcutaneous tesamorelin vs placebo for 26 weeks. -
FDA Notifications: Generic stavudine and efavirenz are tentatively approved by FDA
On Feb. 29, 2008, the FDA granted tentative approval for two generic formulations of drugs used to treat HIV/AIDS. These are stavudine capsules, 15 mg, 20 mg, 30 mg, and 40 mg., and efavirenz tablets, 600 mg, all manufactured by Hetero Drugs Limited, Hyberdad, India. -
AIDS Alert International: International HIV/AIDS groups need to focus more on MSM, amFAR says
HIV-infected men who have sex with men (MSM) in resource-limited countries, often are overlooked, underserved, and discriminated against, international HIV/AIDS advocates say. -
AIDS Alert International: Online, "live" educational conferences teach overseas doctors about HIV treatment
When international funds first became readily available for treating HIV-infected patients in resource-challenged economies, it was clear that many regions lacked trained clinicians for administering HIV antiretroviral treatment.